AU2003205543A1 - Dry dispersions - Google Patents

Dry dispersions

Info

Publication number
AU2003205543A1
AU2003205543A1 AU2003205543A AU2003205543A AU2003205543A1 AU 2003205543 A1 AU2003205543 A1 AU 2003205543A1 AU 2003205543 A AU2003205543 A AU 2003205543A AU 2003205543 A AU2003205543 A AU 2003205543A AU 2003205543 A1 AU2003205543 A1 AU 2003205543A1
Authority
AU
Australia
Prior art keywords
dry dispersions
dispersions
dry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003205543A
Inventor
Anders Buur
Tue Hansen
Per Holm
Kirsten Schultz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lifecycle Pharma AS
Original Assignee
Lifecycle Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifecycle Pharma AS filed Critical Lifecycle Pharma AS
Publication of AU2003205543A1 publication Critical patent/AU2003205543A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
AU2003205543A 2003-01-14 2003-01-14 Dry dispersions Abandoned AU2003205543A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2003/000023 WO2004062643A1 (en) 2003-01-14 2003-01-14 Dry dispersions

Publications (1)

Publication Number Publication Date
AU2003205543A1 true AU2003205543A1 (en) 2004-08-10

Family

ID=32695525

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003205543A Abandoned AU2003205543A1 (en) 2003-01-14 2003-01-14 Dry dispersions

Country Status (2)

Country Link
AU (1) AU2003205543A1 (en)
WO (1) WO2004062643A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US20080318970A1 (en) 2004-04-30 2008-12-25 Birgit Kjaeldgaard Giwercman Treatment of Infectious Diseases
TW200724134A (en) 2005-03-10 2007-07-01 3M Innovative Properties Co Antimicrobial compositions and methods
US10918618B2 (en) 2005-03-10 2021-02-16 3M Innovative Properties Company Methods of reducing microbial contamination
CA2664641A1 (en) 2006-09-26 2008-04-10 Astellas Pharma, Inc. Controlled release dosage form of tacrolimus
CA2674039A1 (en) 2006-12-28 2008-07-17 Astellas Pharma Inc. Sustained release formulation for tacrolimus
WO2008080398A1 (en) 2007-01-05 2008-07-10 Bkg Pharma Aps Anti - infective agents such as phenothiazine and thioxanthene derivates to treat infectious diseases
EP2246349A1 (en) 2009-04-20 2010-11-03 BKG Pharma ApS Treatment of infectious diseases
EP2543364A1 (en) * 2010-10-14 2013-01-09 Deva Holding Anonim Sirketi Formulations of cetyl myristate and/or cetyl palmitate
EP2583673A1 (en) * 2010-10-14 2013-04-24 Deva Holding Anonim Sirketi Coating of cetyl myristate and/or cetyl palmitate particles
EP2471385A1 (en) * 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Cetyl myristate and/or cetyl palmitate suspension formulations
EP2471528A1 (en) * 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi A preparation method for suspension of cetyl myristate and/or cetyl palmitate
EP2471387A1 (en) * 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Cetyl myristate and/or cetyl palmitate suspension formulations
EP2471386A1 (en) * 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Cetyl myristate and/or cetyl palmitate suspension formulations
EP2526936B1 (en) * 2011-05-23 2015-04-15 Deva Holding Anonim Sirketi Particle size distribution of cetyl myristate and/or cetyl palmitate
CA2865972C (en) 2012-02-29 2022-01-04 Pulmatrix, Inc. Inhalable dry powders
CN103099797A (en) * 2013-02-19 2013-05-15 青岛正大海尔制药有限公司 Propylene glycol mannate sulfate capsule and its preparation method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0867666A (en) * 1994-08-29 1996-03-12 Lion Corp Powdery pharmaceutical preparation containing carotenoid and its production
JP4027535B2 (en) * 1998-05-26 2007-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 Powder containing fat-soluble drug
GB0008785D0 (en) * 2000-04-10 2000-05-31 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
WO2004062643A1 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
AU2003205543A1 (en) Dry dispersions
AU2003902455A0 (en) Cadmas
AU2003274573A1 (en) Deburrer
AU2003300235A1 (en) Flooring
AU2003901725A0 (en) Dryer
AU2004905232A0 (en) Dryer
AU2003901420A0 (en) Condition matching
AU2004901495A0 (en) Condition matching
AU2004901583A0 (en) Condition matching
AU2003100378A4 (en) Scootermansydney
AU2003100325A4 (en) Freez-A-Cube
AU2003100198A4 (en) Colourband Browbands
AU2003100006A4 (en) Adcaster
AU2003100942A4 (en) Energenz
AU2003902356A0 (en) The patch
AU2004906412A0 (en) The Pochodyla plug
AU2004901782A0 (en) Costmate 2
AU2004907250A0 (en) Cashramspam 5
AU2003901840A0 (en) Elevation means
AU2003283123A1 (en) The medi-cam
AU2003900333A0 (en) The crab-grab
AU2003900000A0 (en) Sunergy
AU2003900936A0 (en) Mg-zn-al-alloy
AU2003903022A0 (en) Visible-love management-system
AU2003901905A0 (en) Carry-it-pack

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase